Disulfiram inhibits TNF-alpha-induced cell death

A Zhao1, Z Q Wu, M Pollack

  • 1Departments of Medicine, Uniformed Services University, Bethesda, MD 20814, USA.

Cytokine
|September 8, 2000
PubMed

Insights

Disulfiram effectively inhibits tumor necrosis factor-alpha (TNF-alpha)-induced cell death by preserving mitochondrial function and reducing reactive oxygen species. This alcohol deterrent also blocks DNA fragmentation in vivo.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Disulfiram, an alcohol deterrent, is known to inhibit caspase-3 and DNA fragmentation.
  • Tumor necrosis factor-alpha (TNF-alpha) can induce significant cell death.
  • Investigating disulfiram's protective effects against TNF-alpha-induced cell death is crucial.

Purpose of the Study:

  • To determine if disulfiram inhibits TNF-alpha-induced cell death in vitro and in vivo.
  • To elucidate the mechanisms underlying disulfiram's protective effects.

Main Methods:

  • LLC-PK1 cells and murine liver models were used.
  • Cells were treated with TNF-alpha and varying doses of disulfiram.
  • Mitochondrial membrane potential and reactive oxygen species (ROS) were measured.
  • In vivo studies involved TNF-alpha and D-galactosamine treatment in mice.

Main Results:

  • Disulfiram demonstrated dose-dependent inhibition of TNF-alpha-induced cell death and caspase-3-like activity.
  • Disulfiram retained 80% efficacy even when added 4 hours after TNF-alpha.
  • Treatment with disulfiram restored mitochondrial membrane potential and suppressed ROS.
  • In vivo, disulfiram abolished TNF-alpha and D-galactosamine-induced hepatic DNA fragmentation and caspase-3-like activity.

Conclusions:

  • Disulfiram is a potent inhibitor of TNF-alpha-induced cell death.
  • Mechanisms include stabilization of mitochondrial membrane potential, ROS suppression, and caspase-3 inhibition.
  • Disulfiram effectively inhibits DNA fragmentation in vivo via caspase-3 blockade.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...